Last deal

$1.6M
Local Amount - CNY 10M

Amount

Seed

Stage

01.01.2022

Date

2

all rounds

$1.9M

Total amount

General

About Company
Navid Biotech develops simplified and visualized medical detection technologies for nucleic acid detection.

Industry

Sector :

Subsector :

Keywords :

Also Known As

Naide Biotechnology, 耐德生物

founded date

01.08.2016

Number of employees

Company Type

For Profit

Last funding type

Seed

IPO status

Private

Description

Navid Biotech is a biotech firm specializing in the research and development of user-friendly nucleic acid detection technologies. Their offerings include powerful platforms for rapid detection and screening of pathogenic microorganisms, making nucleic acid detection easier and more accessible for customers.